Greenwich LifeSciences, Inc. (GLSI) vs Invivyd, Inc. (IVVD)

Greenwich LifeSciences, Inc. and Invivyd, Inc. are both Biotechnology companies. Greenwich LifeSciences, Inc. and Invivyd, Inc. are of similar size ($274.1M and $265.7M). Greenwich LifeSciences, Inc. has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (0.00% vs −334.9%). Across the 13 metrics below, Greenwich LifeSciences, Inc. leads on 7 and Invivyd, Inc. on 6.

Valuation

Metric GLSI IVVD Biotechnology median
P/E n/m n/m 7.88
P/S n/m 5.11 11.47
P/B 85.47 1.65 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 2.36 10.73
Earnings yield (8.45%) (35.48%) (28.84%)
Free cash flow yield (4.69%) (36.80%) (23.03%)

Profitability

Metric GLSI IVVD Biotechnology median
Gross margin 0.00% 92.23% 65.16%
Operating margin 0.00% (192.81%) 0.00%
Net margin 0.00% (183.90%) 0.00%
Free cash flow margin 0.00% (187.88%) 0.00%
Return on equity (986.31%) (95.89%) (57.72%)
Return on assets (374.46%) (69.69%) (49.22%)
Return on invested capital 0.00% (334.92%) 0.00%

Growth

Metric GLSI IVVD Biotechnology median
Revenue growth (TTM) — 26.30% 5.64%
EPS growth (last fiscal year) (18.18%) 79.02% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI IVVD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 5.87 4.73
Net debt to EBITDA 0.32 4.24 0.96

Dividend

Metric GLSI IVVD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GLSI IVVD Biotechnology median
Market cap 265.68m 274.12m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack